Phase 3, open-label, multicenter safety study of oral edaravone in patients with amyotrophic lateral sclerosis (MT-1186-A01): 48-week results

Saved in:
Bibliographic Details
Published in:Journal of the neurological sciences 2023-12, Vol.455, p.121718, Article 121718
Main Authors: Genge, Angela, Pattee, Gary L., Sobue, Gen, Couratier, Philippe, Selness, Daniel, Bidani, Sachin, Hirai, Manabu, Salah, Alejandro, Apple, Stephen
Format: Article
Language:English
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:0022-510X
DOI:10.1016/j.jns.2023.121718